3 October, 2021 by The TZ Newswire Staff Comments Off on Economic calendar due from Asia today – Monday 4 October 2021
Economic calendar due from Asia today – Monday 4 October 2021
A very light data docket ahead:
2350 GMT Japan monetary base for September
A couple of notes:
3 October, 2021 by The TZ Newswire Staff Comments Off on Asian markets holidays and hours changes heads up
Asian markets holidays and hours changes heads up
A quick note that mainland China is out on holiday today, through to Thursday October 7.
In Australia today:
And, over the weekend, Australian market centres Sydney and Melbourne moved clocks forward one hour to begin daylight saving.
3 October, 2021 by The TZ Newswire Staff Comments Off on This time-tested indicator says the market is going down, and my astrologer agrees
This time-tested indicator says the market is going down, and my astrologer agrees
Wall Street soothsayer Henry Weingarten has a strong record of using the stars to help clients decide when to buy and sell stocks
To view the full story, click the title link.
3 October, 2021 by The TZ Newswire Staff Comments Off on ECB’s Visco (Governor of the Bank of Italy) says price pressures are temporary
ECB’s Visco (Governor of the Bank of Italy) says price pressures are temporary
European Central Bank Governing Council member Ignazio Visco spoke on Saturday, said inflation is being driven by commodity price rises and supply chain issues.
3 October, 2021 by The TZ Newswire Staff Comments Off on Former ECB President Trichet sceptical that US inflation is transitory
Former ECB President Trichet sceptical that US inflation is transitory
Says European Union inflation is transitory but is wary that in the US its not.
Was speaking in an interview on Satuday:
– “There is a big difference”
3 October, 2021 by The TZ Newswire Staff Comments Off on 3 Things to Watch in the Stock Market This Week
3 Things to Watch in the Stock Market This Week
Stocks fell last week to close out a rough month for indexes. Both the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) shed over 2.5% in September. Yet stocks are still significantly higher so far in 2021.
3 October, 2021 by The TZ Newswire Staff Comments Off on Active Biotech: Utvecklingen av tasquinimod i multipelt myelom fortsätter i kombinationsbehandling efter att den inledande fasen av den pågående studien i USA slutförts
Active Biotech: Utvecklingen av tasquinimod i multipelt myelom fortsätter i kombinationsbehandling efter att den inledande fasen av den pågående studien i USA slutförts
Lund, 3 oktober 2021 – Active Biotech (NASDAQ STOCKHOLM: ACTI) meddelar idag att den pågående kliniska studien med tasquinimod i multipelt myelom har nått en viktig milstolpe. Tio patienter har behandlats med ökande doser av tasquinimod, vilket i allmänhet tolererades väl. Den optimala dosen och behandlingsschemat för tasquinimod, när det används som monoterapi i patienter med multipelt myelom, har fastställts till 1 mg per dag efter en veckas uppstart med 0,5 mg dagligen. Detta är jämförbart med det behandlingsschema som använts i tidigare studier med tasquinimod.